+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunohistochemistry Market Research Report by Product (Antibodies, Equipment, and Kits), Application, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5137198
  • Report
  • April 2022
  • Region: Global
  • 196 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abcam PLC
  • Biocare Medical, LLC
  • Candor Bioscience GmbH
  • Eagle Biosciences, Inc.
  • GenomeMe
  • Miltenyi Biotec
The Global Immunohistochemistry Market size was estimated at USD 2,188.18 million in 2021, USD 2,419.03 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.72% to reach USD 4,032.74 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Immunohistochemistry to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Antibodies, Equipment, Kits, and Reagents. The Antibodies is further studied across Primary Antibodies and Secondary Antibodies. The Equipment is further studied across Slide Scanners, Slide Staining Systems, Tissue Microarrays, and Tissue Processing Systems. The Reagents is further studied across Blocking Sera and Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Proteolytic Enzymes, and Stabilizers.
  • Based on Application, the market was studied across Diagnostics, Drug Testing, and Forensic. The Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Diabetes Mellitus, Infectious Diseases, and Nephrological Diseases.
  • Based on End-user, the market was studied across Academic & Research Institutes, CROs, Forensic Labs, Hospitals & Diagnostic Laboratories, and Pharma & Biopharma Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Immunohistochemistry market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Immunohistochemistry Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Immunohistochemistry Market, including Abcam PLC, Agilent Technologies, Inc., Bio SB, Inc., Bio-Rad Laboratories, Inc., Biocare Medical, LLC, Biogenex Laboratories, Candor Bioscience GmbH, Cell Signaling Technology, Inc., Danaher Corporation, Diagnostic BioSystems Inc., Eagle Biosciences, Inc., F. Hoffmann-La Roche AG, GenomeMe, Merck KGaA, Miltenyi Biotec, NeoGenomics Laboratories, Inc., Perkinelmer, Inc., Sakura Finetek Japan Co.,Ltd., Sino Biological Inc., and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Immunohistochemistry Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunohistochemistry Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunohistochemistry Market?
4. What is the competitive strategic window for opportunities in the Global Immunohistochemistry Market?
5. What are the technology trends and regulatory frameworks in the Global Immunohistochemistry Market?
6. What is the market share of the leading vendors in the Global Immunohistochemistry Market?
7. What modes and strategic moves are considered suitable for entering the Global Immunohistochemistry Market?
Frequently Asked Questions about the Global Immunohistochemistry Market

What is the estimated value of the Global Immunohistochemistry Market?

The Global Immunohistochemistry Market was estimated to be valued at $2188.2 Million in 2021.

What is the growth rate of the Global Immunohistochemistry Market?

The growth rate of the Global Immunohistochemistry Market is 10.7%, with an estimated value of $4032.7 Million by 2027.

What is the forecasted size of the Global Immunohistochemistry Market?

The Global Immunohistochemistry Market is estimated to be worth $4032.7 Million by 2027.

Who are the key companies in the Global Immunohistochemistry Market?

Key companies in the Global Immunohistochemistry Market include Abcam PLC, Agilent Technologies, Inc., Bio SB, Inc., Bio, Rad Laboratories, Inc., Biocare Medical, LLC, Biogenex Laboratories, Candor Bioscience GmbH and Danaher Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam PLC
  • Biocare Medical, LLC
  • Candor Bioscience GmbH
  • Eagle Biosciences, Inc.
  • GenomeMe
  • Miltenyi Biotec

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
5.1.1.2. Development of technologically advanced IHC solutions coupled with rising product approvals
5.1.1.3. Increasing drug discoveries and development activities
5.1.2. Restraints
5.1.2.1. Capital intensive setup and dearth of specificity in IHC solutions
5.1.3. Opportunities
5.1.3.1. Merging collaborations between pharmaceutical companies and players involved in IHC development
5.1.3.2. Growing demand for personalized/customized medicine
5.1.4. Challenges
5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Immunohistochemistry Market, by Product
6.1. Introduction
6.2. Antibodies
6.2.1. Primary Antibodies
6.2.2. Secondary Antibodies
6.3. Equipment
6.3.1. Slide Scanners
6.3.2. Slide Staining Systems
6.3.3. Tissue Microarrays
6.3.4. Tissue Processing Systems
6.4. Kits
6.5. Reagents
6.5.1. Blocking Sera and Reagents
6.5.2. Chromogenic Substrates
6.5.3. Diluents
6.5.4. Fixation Reagents
6.5.5. Histological Stains
6.5.6. Organic Solvents
6.5.7. Proteolytic Enzymes
6.5.8. Stabilizers
7. Immunohistochemistry Market, by Application
7.1. Introduction
7.2. Diagnostics
7.2.1. Autoimmune Diseases
7.2.2. Cancer
7.2.3. Cardiovascular Diseases
7.2.4. Diabetes Mellitus
7.2.5. Infectious Diseases
7.2.6. Nephrological Diseases
7.3. Drug Testing
7.4. Forensic
8. Immunohistochemistry Market, by End-user
8.1. Introduction
8.2. Academic & Research Institutes
8.3. CROs
8.4. Forensic Labs
8.5. Hospitals & Diagnostic Laboratories
8.6. Pharma & Biopharma Companies
9. Americas Immunohistochemistry Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Immunohistochemistry Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Immunohistochemistry Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abcam PLC
13.2. Agilent Technologies, Inc.
13.3. Bio SB, Inc.
13.4. Bio-Rad Laboratories, Inc.
13.5. Biocare Medical, LLC
13.6. Biogenex Laboratories
13.7. Candor Bioscience GmbH
13.8. Cell Signaling Technology, Inc.
13.9. Danaher Corporation
13.10. Diagnostic BioSystems Inc.
13.11. Eagle Biosciences, Inc.
13.12. F. Hoffmann-La Roche AG
13.13. GenomeMe
13.14. Merck KGaA
13.15. Miltenyi Biotec
13.16. NeoGenomics Laboratories, Inc.
13.17. Perkinelmer, Inc.
13.18. Sakura Finetek Japan Co.,Ltd.
13.19. Sino Biological Inc.
13.20. Thermo Fisher Scientific, Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: DYNAMICS
FIGURE 2. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 42. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2027
FIGURE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 45. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 46. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, 2019-2027 (USD MILLION)
FIGURE 47. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 48. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 49. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 50. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD MILLION)
FIGURE 51. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, 2019-2027 (USD MILLION)
FIGURE 61. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 62. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 63. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2027
FIGURE 65. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 67. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, 2019-2027 (USD MILLION)
FIGURE 68. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 69. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, 2019-2027 (USD MILLION)
FIGURE 70. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 71. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 72. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 73. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, 2019-2027 (USD MILLION)
FIGURE 74. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 75. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 96. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 97. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: FPNV POSITIONING MATRIX
FIGURE 106. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 107. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2019-2027 (USD MILLION)
TABLE 35. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY STATE, 2019-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 70. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2019-2027 (USD MILLION)
TABLE 75. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY STATE, 2019-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 80. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2019-2027 (USD MILLION)
TABLE 85. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY STATE, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 89. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 94. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 95. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 96. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 97. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 98. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 101. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 102. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 103. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 106. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 107. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 108. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 110. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 111. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 113. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 115. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2019-2027 (USD MILLION)
TABLE 116. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY STATE, 2019-2027 (USD MILLION)
TABLE 118. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 120. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 121. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 123. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 131. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 132. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 133. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 136. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 137. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 138. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 140. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 141. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 142. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 143. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 144. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 146. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2019-2027 (USD MILLION)
TABLE 147. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 148. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY STATE, 2019-2027 (USD MILLION)
TABLE 149. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 151. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2019-2027 (USD MILLION)
TABLE 152. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 153. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY STATE, 2019-2027 (USD MILLION)
TABLE 154. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 156. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 157. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 158. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 159. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 161. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 162. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 163. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 164. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 166. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 172. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 175. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 176. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 177. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 180. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 181. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 182. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 183. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 185. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 186. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 187. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 188. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 190. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 191. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 192. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 195. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 196. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SCORES
TABLE 197. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BUSINESS STRATEGY
TABLE 198. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: PRODUCT SATISFACTION
TABLE 199. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: RANKING
TABLE 200. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 201. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: MERGER & ACQUISITION
TABLE 202. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 203. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 204. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: INVESTMENT & FUNDING
TABLE 205. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 206. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abcam PLC
  • Agilent Technologies, Inc.
  • Bio SB, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • Biogenex Laboratories
  • Candor Bioscience GmbH
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Diagnostic BioSystems Inc.
  • Eagle Biosciences, Inc.
  • F. Hoffmann-La Roche AG
  • GenomeMe
  • Merck KGaA
  • Miltenyi Biotec
  • NeoGenomics Laboratories, Inc.
  • Perkinelmer, Inc.
  • Sakura Finetek Japan Co.,Ltd.
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...